These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 36528754)
21. Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome. Santiago V; Lazaryan A; McClune B; McKenna RW; Courville EL Leuk Lymphoma; 2018 Apr; 59(4):958-966. PubMed ID: 28728454 [TBL] [Abstract][Full Text] [Related]
25. Prediction of infectious events by the high-sensitivity C-reactive protein level before autologous hematopoietic cell transplantation for lymphoma and multiple myeloma. Sato M; Nakasone H; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Kawamura K; Ashizawa M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Tanihara A; Yamazaki R; Tanaka Y; Kanda J; Kako S; Nishida J; Kanda Y Transpl Infect Dis; 2013 Aug; 15(4):E169-71. PubMed ID: 23782409 [No Abstract] [Full Text] [Related]
26. Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial. Russell N; Douglas K; Ho AD; Mohty M; Carlson K; Ossenkoppele GJ; Milone G; Pareja MO; Shaheen D; Willemsen A; Whitaker N; Chabannon C Haematologica; 2013 Feb; 98(2):172-8. PubMed ID: 22983579 [TBL] [Abstract][Full Text] [Related]
27. Myeloma stem cells in autografting in multiple myeloma. To LB; Horvath N; Dyson P; Henry J; Sykes P; Brisco M; Morley A; Bennetts B J Hematother; 1996 Oct; 5(5):557-9. PubMed ID: 8938529 [TBL] [Abstract][Full Text] [Related]
28. Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma. Nagayama T; Ashizawa M; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Mashima K; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y Ann Hematol; 2020 Dec; 99(12):2893-2901. PubMed ID: 32572522 [TBL] [Abstract][Full Text] [Related]
30. Toward a more rational policy for autologous hematopoietic stem cell mobilization. Devine SM Biol Blood Marrow Transplant; 2012 Oct; 18(10):1468-70. PubMed ID: 22892553 [No Abstract] [Full Text] [Related]
31. Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life. Georges GE; Bar M; Onstad L; Yi JC; Shadman M; Flowers ME; Carpenter PA; Stewart S; Lee SJ; Holmberg LA Biol Blood Marrow Transplant; 2020 Feb; 26(2):407-412. PubMed ID: 31605822 [TBL] [Abstract][Full Text] [Related]
32. The costs of mobilisation and collection of peripheral blood stem cells in multiple myeloma and lymphoma in an European country: results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey. Pierelli L; Berto P; Accorsi P; Milone G; Lopatriello S; Aiello A; Iacopino P; Olivieri A; Rambaldi A; Bosi A Transfus Apher Sci; 2013 Dec; 49(3):615-22. PubMed ID: 23973731 [TBL] [Abstract][Full Text] [Related]
33. Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Chong CY Clin J Oncol Nurs; 2022 Jun; 26(3):252-256. PubMed ID: 35604735 [TBL] [Abstract][Full Text] [Related]
34. Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematological recovery. Ungerstedt JS; Watz E; Uttervall K; Johansson BM; Wahlin BE; Näsman P; Ljungman P; Gruber A; Axdorph Nygell U; Nahi H Med Oncol; 2012 Sep; 29(3):2191-9. PubMed ID: 21779930 [TBL] [Abstract][Full Text] [Related]
35. Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels. Eicher F; Mansouri Taleghani B; Schild C; Bacher U; Pabst T Hematol Oncol; 2020 Oct; 38(4):523-530. PubMed ID: 32594534 [TBL] [Abstract][Full Text] [Related]
36. Association of oxidative stress and DNA damage with grafting time in patients with multiple myeloma and lymphoma submitted to autologous hematopoietic stem cell transplantation. Santos TN; Duarte FB; Maia Filho PA; Santos TE; Barbosa MC; Almeida Filho TP; Cavalcanti BC; Vasconcelos PR; Dutra LL; Lopes GS; Costa FO; Leitão JP; KauFman J; AraúJo BS; Barroso KS; Lemes RP Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():39-43. PubMed ID: 27982318 [TBL] [Abstract][Full Text] [Related]
37. Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation. Chitre S; Stölzel F; Cuthill K; Streetly M; Graham C; Dill C; Mohamedali A; Smith A; Schetelig J; Altmann H; Bornhäuser M; Mufti GJ Leukemia; 2018 Sep; 32(9):2020-2024. PubMed ID: 30026569 [No Abstract] [Full Text] [Related]
38. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506 [TBL] [Abstract][Full Text] [Related]
39. Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma. Moor I; Bacher VU; Jeker B; Taleghani BM; Mueller BU; Keller P; Betticher D; Egger T; Novak U; Pabst T Bone Marrow Transplant; 2018 Dec; 53(12):1599-1602. PubMed ID: 29884856 [No Abstract] [Full Text] [Related]
40. Autologous hematopoietic cell transplantation: an update for clinicians. Hamadani M Ann Med; 2014 Dec; 46(8):619-32. PubMed ID: 25211470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]